1)bevacizumab贝伐单抗
1.Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice;贝伐单抗对荷耐顺铂人肺腺癌A549/DDP裸鼠皮下移植瘤生长的影响
2.Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer;贝伐单抗联合依立替康、氟尿嘧啶/甲酰四氢叶酸对转移性结直肠癌的治疗
3.Assessment of the Efficacy and Safety of Bevacizumab Plus Carboplatin and Paclitaxel in Patients with Non-Small Cell Lung Cancer;贝伐单抗联合卡铂加紫杉醇在非小细胞肺癌中的疗效与安全性评价
英文短句/例句
1.Experimental Study on Reversion of Human Nasopharyngeal Carcinoma Drug-Resistance by Bevacizumab;贝伐单抗逆转鼻咽癌耐药的实验研究
2.Toxicity of Bevacizumab in the Treatment for Cancer贝伐单抗在肿瘤治疗中相关毒副反应
3.Curative Effect of Subconjunctival Injection of Bevacizumab on Angiogenesis in Alkali Burn Cornea of Rats贝伐单抗抑制碱烧伤角膜新生血管的实验研究
4.Effects of Bevacizumab on Apoptosis in Drug-Resistant Nasopharyngeal Carcinoma Cells贝伐单抗对耐药鼻咽癌细胞凋亡的影响
5.Effect of topical bevacizumab on experimental corneal neovascularization in mouse贝伐单抗抑制角膜新生血管的实验研究
6.Inhibitory Effect of Vascular Endothelial Growth Factor Antibody Bevacizumab Combined with rAd5/p53 on Osteosarcoma in Nude Mice贝伐单抗联合重组人p53腺病毒治疗骨肉瘤
7.Anti-proliferative effect of bevacizumab on liver cancer cell HepG2贝伐单抗对肝癌细胞株HepG2增殖的抑制作用
8.The Hot Spot of Bevacizumab in the Treatment of Non-small Cell Lung Cancer贝伐单抗靶向治疗非小细胞肺癌研究热点
9.Acceptable Safety of Bevacizumab Therapy in Combination with Chemotherapy in Patients with Advanced Lung Cancer贝伐单抗联合化疗治疗晚期肺癌的安全性观察
10.Studies of Metronomic Chemotherapy and Bevacizumab for the Nude Mice Model of Human Hepatocellular Carcinoma;节拍性化疗及贝伐单抗治疗肝癌裸鼠模型的实验研究
11.Effects of Bevacizumab in Combination with Cisplatin on Tumor Growth of Human Lung Adenocarcinoma(A549/DDP) Xenografts in Nude Mice;贝伐单抗联合顺铂对荷人肺腺癌A549/DDP裸鼠皮下移植瘤生长的影响
12.Treatment of Avastin in Oxygen-Induced Retinopathy of Prematurity in the Mouse贝伐单抗对大鼠氧诱导视网膜病变治疗作用机制的实验研究
13.Distribution and Toxic Effect of Intracameral Injection of Bevacizumab in Rabbit Eyes兔眼前房注射贝伐单抗的药物分布及毒副作用的实验研究
14.Recombinant adenovirus APE1 siRNA enhances efficacy of bevacizumab on implanted osteosarcomaAPE1 siRNA重组腺病毒增强贝伐单抗对移植骨肉瘤的治疗作用
15.Changes of photopic negative response in patients with exudative age-related macular degeneration and proliferative diabetic retinopathy after intravitreal injections of bevacizumab玻璃体腔内注射贝伐单抗后视网膜电图明视负向反应改变
16.Studies on the inhibitory effect of bevacizumab on angiogenesis in osteosarcoma and the synergetic effcet of bevacizumab with radiotherapy in nude mice贝伐单抗抑制骨肉瘤血管生成及与放疗的协同作用研究
17.Intravitreous bevacizumab(Avastin) therapy for diffuse diabetic macular edema玻璃体腔注射贝伐单抗治疗糖尿病性黄斑水肿疗效观察
18.Clinical Curative Effect of Bevacizumab Combined PB Project to Treat Cervical Carcinoma in Middle and Late Stage贝伐单抗联合PB方案治疗中晚期宫颈癌的临床观察
相关短句/例句
MMP-9 AvastinMMP-9贝伐单抗
3)Bevacizumab (Avastin)贝伐单抗(阿瓦斯丁)
4)Bectumomab贝妥莫单抗
5)logging unit(change);felling unit伐木单位
6)exploitation cutting(felling)单纯利用伐
延伸阅读
贝罗贝特 ,苄氯贝特药物名称：苄氯贝特英文名：别名： 贝罗贝特 ,苄氯贝特 药理作用： 本品的降血脂作用很强，强于氯贝丁酯20倍，有降低血中胆固醇、甘油三酯、极低密度和低密度脂蛋白的作用，而使高密度脂蛋白升高。还具抗血小板聚集作用。 口服后由肠内吸收较快，2-6小时血药浓度达峰值。与血浆蛋白结合率高；体内分布较广，肌肉和生殖器中很少。代谢产物大部分随尿排出，少量随便排出，半衰期约为15-17小时。 适应症：： 用于各型高脂蛋血症及单用饮食疗法未能控制的高脂血症患者，也可用于有并发症（如：糖尿病、肾病、胰腺炎、肝硬化）或某些药物引起的血脂升高的患者。 用法用量： 口服：100mg/次，晚餐后服1次。 注意事项： 1、中、重度肝肾功能障碍者，孕妇和哺乳期妇女禁用，小儿慎用。 2、控制剂量不超过100mg/日，定期检测肝肾功能及血脂。 3、服药3个月后，血脂下降不明显，应采用其它辅助疗法。 规格： 胶囊剂：100mg/粒。 类别：降血脂药
